title: Downstream processing of cell culture-derived virus particles.
abstract: Manufacturing of cell culture-derived virus particles for vaccination and gene therapy is a rapidly growing field in the biopharmaceutical industry. The process involves a number of complex tasks and unit operations ranging from selection of host cells and virus strains for the cultivation in bioreactors to the purification and formulation of the final product. For the majority of cell culture-derived products, efforts focused on maximization of bioreactor yields, whereas design and optimization of downstream processes were often neglected. Owing to this biased focus, downstream procedures today often constitute a bottleneck in various manufacturing processes and account for the majority of the overall production costs. For efficient production methods, particularly in sight of constantly increasing economic pressure within human healthcare systems, highly productive downstream schemes have to be developed. Here, we discuss unit operations and downstream trains to purify virus particles for use as vaccines and vectors for gene therapy.
authors: Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Sandtorstrasse 1, 39106 Magdeburg, Germany. mwolff@mpi-magdeburg.mpg.de
authors: Michael W
authors: MW
authors: Wolf
authors: Udo
authors: U
authors: Reichl
mesh_terms: D018929:Cell Culture Techniques; D011232:Chemical Precipitation; D002845:Chromatography / Q000379:methods; D005374:Filtration / Q000379:methods; D005427:Flocculation; D015316:Genetic Therapy; D005822:Genetic Vectors; D014612:Vaccines; D014771:Virion
chemical_list: D014612:Vaccines